Alpha-ketoglutarate ameliorates pressure overload-induced chronic cardiac dysfunction in mice.
Alpha-ketoglutarate ameliorates pressure overload-induced chronic cardiac dysfunction in mice.
复制标题
DOI:
10.1016/j.redox.2021.102088
复制
发表时间:
2021-10
期刊:
影响因子:
11.4
通讯作者:
Xu D
中科院分区:
文献类型:
--
作者:
An D;Zeng Q;Zhang P;Ma Z;Zhang H;Liu Z;Li J;Ren H;Xu D
Increasing evidence indicates the involvement of myocardial oxidative injury and mitochondrial dysfunction in the pathophysiology of heart failure (HF). Alpha-ketoglutarate (AKG) is an intermediate metabolite of the tricarboxylic acid (TCA) cycle that participates in different cellular metabolic and regulatory pathways. The circulating concentration of AKG was found to decrease with ageing and is elevated after acute exercise and resistance exercise and in HF. Recent studies in experimental models have shown that dietary AKG reduces reactive oxygen species (ROS) production and systemic inflammatory cytokine levels, regulates metabolism, extends lifespan and delays the occurrence of age-related decline. However, the effects of AKG on HF remain unclear. In the present study, we explored the effects of AKG on left ventricular (LV) systolic function, the myocardial ROS content and mitophagy in mice with transverse aortic constriction (TAC). AKG supplementation inhibited pressure overload-induced myocardial hypertrophy and fibrosis and improved cardiac systolic dysfunction; in vitro, AKG decreased the Ang II-induced upregulation of β-MHC and ANP, reduced ROS production and cardiomyocyte apoptosis, and repaired Ang II-mediated injury to the mitochondrial membrane potential (MMP). These benefits of AKG in the TAC mice may have been obtained by enhanced mitophagy, which cleared damaged mitochondria. In summary, our study suggests that AKG improves myocardial hypertrophy remodelling, fibrosis and LV systolic dysfunction in the pressure-overloaded heart by promoting mitophagy to clear damaged mitochondria and reduce ROS production; thus, AKG may have therapeutic potential for HF. AKG attenuated pressure overload-induced myocardial fibrosis and hypertrophy remodelling. AKG improved cardiac function and left ventricular strain in TAC mice. AKG increased myocardial mitophagy to clear damaged mitochondria and rescued Ang II-induced MMP impairment in TAC mice. AKG reduced intracellular ROS and myocardial apoptosis in the pressure overloaded heart.
登录
查看更多内容
DOI:
10.1093/gerona/gly139
发表时间:
2019-03-14
期刊:
The journals of gerontology. Series A, Biological sciences and medical sciences
影响因子:
--
作者:
de Lucia C;Wallner M;Eaton DM;Zhao H;Houser SR;Koch WJ
通讯作者:
Koch WJ
影响因子:
24
作者:
Cheng, Mei-Ling;Wang, Chao-Hung;Yang, Ning-I
通讯作者:
Yang, Ning-I
影响因子:
7.5
作者:
Liu, Zuheng;Ma, Zhuang;Xu, Dingli
通讯作者:
Xu, Dingli
影响因子:
2
作者:
Guo, Shuangshuang;Duan, Rui;Ding, Binying
通讯作者:
Ding, Binying
影响因子:
37.8
作者:
Nayor M;Shah RV;Miller PE;Blodgett JB;Tanguay M;Pico AR;Murthy VL;Malhotra R;Houstis NE;Deik A;Pierce KA;Bullock K;Dailey L;Velagaleti RS;Moore SA;Ho JE;Baggish AL;Clish CB;Larson MG;Vasan RS;Lewis GD
通讯作者:
Lewis GD